Previous 10 | Next 10 |
MISONIX (NASDAQ: MSON ): Q3 GAAP EPS of -$0.17 beats by $0.01 . More news on: Misonix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
FARMINGDALE, N.Y., May 08, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today reported financial results for the fisca...
Misonix, Inc. (MSON) Acquisition of Solsys Medical Call May 3, 2019 8:30 AM ET Company Participants Norberto Aja – Investor Relations Stavros Vizirgianakis – President and Chief Executive Officer Allan Staley – Chief Executive Officer-Solsys Medical, LLC Jo...
Transaction Creates Medical Device Company with Comprehensive Portfolio of Wound Care Solutions to Improve Healthcare Outcomes Combined Entity to Generate Over $80 Million in Annual Revenue for Fiscal 2020 FARMINGDALE, N.Y., May 02, 2019 (GLOBE NEWSWIRE) -- Misonix, I...
FARMINGDALE, N.Y., April 10, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report its fi...
FARMINGDALE, N.Y., March 06, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will be participatin...
FARMINGDALE, N.Y., March 04, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that Sharon Klugewicz has be...
FARMINGDALE, N.Y., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will be participating...
Misonix, Inc. (MSON) Q2 2019 Results Earnings Conference Call February 7, 2019, 04:30 PM ET Company Participants Norberto Aja - Investor Contact, JCIR Stavros Vizirgianakis - President and Chief Executive Officer Joseph Dwyer - Chief Financial Officer Conference Call Participa...
MISONIX (NASDAQ: MSON ): Q2 GAAP EPS of -$0.09 beats by $0.08 . More news on: MISONIX, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the “Election Deadline...
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaud...